Literature DB >> 1436274

Drug interaction of chloroquine with ciclosporin.

M R Nampoory, J Nessim, R K Gupta, K V Johny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1436274     DOI： 10.1159/000187007

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  11 in total

Review 1.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

2.  Postrenal transplant Plasmodium vivax malaria: neglected and not benign.

Authors:  Vivek B Kute; Aruna V Vanikar; Pankaj R Shah; Jigar D Shrimali; Manoj R Gumber; Himanshu V Patel; Pranjal R Modi; Hargovind L Trivedi
Journal:  Parasitol Res       Date:  2012-12-13       Impact factor: 2.289

Review 3.  Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine.

Authors:  Mariana Babayeva; Zvi Loewy
Journal:  Pharmgenomics Pers Med       Date:  2020-10-23

Review 4.  Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.

Authors:  Laure Elens; Loralie J Langman; Dennis A Hesselink; Stein Bergan; Dirk Jan A R Moes; Mariadelfina Molinaro; Raman Venkataramanan; Florian Lemaitre
Journal:  Ther Drug Monit       Date:  2020-06       Impact factor: 3.681

Review 5.  Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications.

Authors:  Rajnish Kumar; Anju Sharma; Janmejai Kumar Srivastava; Mohammed Haris Siddiqui; Md Sahab Uddin; Lotfi Aleya
Journal:  Environ Sci Pollut Res Int       Date:  2021-01-15       Impact factor: 4.223

Review 6.  Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents.

Authors:  Shagun B Shah; Uma Hariharan; Rajiv Chawla
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-07-15

Review 7.  Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.

Authors:  Cornelis Smit; Mariska Y M Peeters; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

Review 8.  American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States.

Authors:  Zahra Mahmoudjafari; Maurice Alexander; Julianna Roddy; Ryan Shaw; Terri Lynn Shigle; Colleen Timlin; Katie Culos
Journal:  Biol Blood Marrow Transplant       Date:  2020-04-17       Impact factor: 5.742

9.  Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics.

Authors:  Soufian Meziyerh; Tom C Zwart; Ronald W van Etten; Jeroen A Janson; Teun van Gelder; Ian P J Alwayn; Johan W de Fijter; Marlies E J Reinders; Dirk J A R Moes; Aiko P J de Vries
Journal:  Am J Transplant       Date:  2020-05-13       Impact factor: 9.369

Review 10.  Antivirals for COVID-19 in Solid Organ Transplant Recipients.

Authors:  Justin C Laracy; Elizabeth C Verna; Marcus R Pereira
Journal:  Curr Transplant Rep       Date:  2020-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.